| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-09-4210 |
| P698 | PubMed publication ID | 20484035 |
| P2093 | author name string | Yoh Zen | |
| Tatsuya Yamashita | |||
| Taro Yamashita | |||
| Shuichi Kaneko | |||
| Hiroyuki Takamura | |||
| Takashi Tani | |||
| Masao Honda | |||
| Yasunari Nakamoto | |||
| Kouki Nio | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| liver cancer | Q623031 | ||
| cell adhesion | Q187640 | ||
| fluorouracil | Q238512 | ||
| P304 | page(s) | 4687-4697 | |
| P577 | publication date | 2010-05-18 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation | |
| P478 | volume | 70 |
| Q36772115 | Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma. |
| Q40648635 | Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA). |
| Q37873961 | Biology of hepatic cancer stem cells. |
| Q35060898 | Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin |
| Q26779931 | Cancer stem cell targeted therapy: progress amid controversies. |
| Q37129887 | Cancer stem cells in breast cancer |
| Q38540375 | Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q38174864 | Cellular reprogramming and hepatocellular carcinoma development |
| Q34357073 | Clinical implications of cancer stem cell biology in hepatocellular carcinoma |
| Q38969367 | De Novo Emergence of Mesenchymal Stem-Like CD105+ Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma |
| Q55312702 | Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET. |
| Q58577525 | Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells |
| Q61451666 | Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133 HepG2 liver cancer cells |
| Q38811582 | Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model. |
| Q28383729 | From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms |
| Q34079695 | Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma |
| Q33820241 | HiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression |
| Q28534312 | IL-6 regulates Mcl-1L expression through the JAK/PI3K/Akt/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regeneration |
| Q90313125 | Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma |
| Q64996870 | Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors. |
| Q35112032 | Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection |
| Q33756006 | Molecular biology of liver cancer stem cells |
| Q41979111 | Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. |
| Q34940971 | Novel therapeutic strategies for targeting liver cancer stem cells |
| Q47739621 | Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma |
| Q37596687 | Properties and feasibility of using cancer stem cells in clinical cancer treatment |
| Q39007383 | RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription |
| Q38552115 | Recent insights into hepatic cancer stem cells |
| Q33940830 | Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study. |
| Q28279753 | Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers |
| Q39109959 | The evolving concept of liver cancer stem cells |
| Q37428403 | The role of microRNAs in the regulation of cancer stem cells |
| Q36887716 | Therapeutic strategies targeting cancer stem cells |
| Q38008950 | Translational medicine in hepatocellular carcinoma |
| Q38411340 | miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence |
Search more.